A Hernández-Tejedor1, M C Martín Delgado2, L Cabré Pericas3, A Algora Weber4. 1. Unidad de Cuidados Críticos, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España. Electronic address: albertohmed@hotmail.com. 2. Unidad de Cuidados Intensivos, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, España. 3. Unidad de Cuidados Intensivos, Hospital de Barcelona SCIAS, Barcelona, España. 4. Unidad de Cuidados Críticos, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España.
Abstract
OBJECTIVE: Limitation of life-sustaining treatment (LLST) is a recommended practice in certain circumstances. Limitation practices are varied, and their application differs from one center to another. The present study evaluates the current situation of LLST practices in patients with prolonged admission to the ICU who suffer worsening of their condition. DESIGN: A prospective, observational cohort study was carried out. SETTING: Seventy-five Spanish ICUs. PATIENTS: A total of 589 patients suffering 777 complications or adverse events with organ function impairment after day 7 of admission, during a three-month recruitment period. MAIN VARIABLES OF INTEREST: The timing of limitation, the subject proposing LLST, the degree of agreement within the team, the influence of LLST upon the doctor-patient-family relationship, and the way in which LLST is implemented. RESULTS: LLST was proposed in 34.3% of the patients presenting prolonged admission to the ICU with severe complications. The incidence was higher in patients with moderate to severe lung disease, cancer, immunosuppressive treatment or dependence for basic activities of daily living. LLST was finally implemented in 97% of the cases in which it was proposed. The decision within the medical team was unanimous in 87.9% of the cases. The doctor-patient-family relationship usually does not change or even improves in this situation. CONCLUSION: LLST in ICUs is usually carried out under unanimous decision of the medical team, is performed more frequently in patients with severe comorbidity, and usually does not have a negative impact upon the relationship with the patients and their families.
OBJECTIVE: Limitation of life-sustaining treatment (LLST) is a recommended practice in certain circumstances. Limitation practices are varied, and their application differs from one center to another. The present study evaluates the current situation of LLST practices in patients with prolonged admission to the ICU who suffer worsening of their condition. DESIGN: A prospective, observational cohort study was carried out. SETTING: Seventy-five Spanish ICUs. PATIENTS: A total of 589 patients suffering 777 complications or adverse events with organ function impairment after day 7 of admission, during a three-month recruitment period. MAIN VARIABLES OF INTEREST: The timing of limitation, the subject proposing LLST, the degree of agreement within the team, the influence of LLST upon the doctor-patient-family relationship, and the way in which LLST is implemented. RESULTS: LLST was proposed in 34.3% of the patients presenting prolonged admission to the ICU with severe complications. The incidence was higher in patients with moderate to severe lung disease, cancer, immunosuppressive treatment or dependence for basic activities of daily living. LLST was finally implemented in 97% of the cases in which it was proposed. The decision within the medical team was unanimous in 87.9% of the cases. The doctor-patient-family relationship usually does not change or even improves in this situation. CONCLUSION: LLST in ICUs is usually carried out under unanimous decision of the medical team, is performed more frequently in patients with severe comorbidity, and usually does not have a negative impact upon the relationship with the patients and their families.
Keywords:
Bioethics; Bioética; Decision making; Decisiones al final de la vida; Life-sustaining treatment; Multiple organ dysfunction syndrome; Síndrome de disfunción multiorgánica; Tratamientos de soporte vital
Authors: Olga Rubio; Anna Arnau; Sílvia Cano; Carles Subirà; Begoña Balerdi; María Eugenía Perea; Miguel Fernández-Vivas; María Barber; Noemí Llamas; Susana Altaba; Ana Prieto; Vicente Gómez; Mar Martin; Marta Paz; Belen Quesada; Valentí Español; Juan Carlos Montejo; José Manuel Gomez; Gloria Miro; Judith Xirgú; Ana Ortega; Pedro Rascado; Juan María Sánchez; Alfredo Marcos; Ana Tizon; Pablo Monedero; Elisabeth Zabala; Cristina Murcia; Ines Torrejon; Kenneth Planas; José Manuel Añon; Gonzalo Hernandez; María-Del-Mar Fernandez; Consuelo Guía; Vanesa Arauzo; José Miguel Perez; Rosa Catalan; Javier Gonzalez; Rosa Poyo; Roser Tomas; Iñaki Saralegui; Jordi Mancebo; Charles Sprung; Rafael Fernández Journal: J Intensive Care Date: 2018-04-13
Authors: Angela M Kotsopoulos; Nichon E Jansen; Piet Vos; Marloes Witjes; Meint Volbeda; Jelle L Epker; Hans P C Sonneveld; Koen S Simons; Ewald M Bronkhorst; Hans G van der Hoeven; Wilson F Abdo Journal: Am J Transplant Date: 2020-08-26 Impact factor: 8.086
Authors: Ò Miró; A Alquézar-Arbé; P Llorens; F J Martín-Sánchez; S Jiménez; A Martín; G Burillo-Putze; J Jacob; E J García-Lamberechts; P Piñera; J González Del Castillo Journal: Med Intensiva (Engl Ed) Date: 2020-09-29
Authors: Esther N van der Zee; Jelle L Epker; Jan Bakker; Dominique D Benoit; Erwin J O Kompanje Journal: J Intensive Care Med Date: 2020-08-13 Impact factor: 3.510